XPC promotes MDM2-mediated degradation of the p53 tumor suppressor. 2014

Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai 200433, People's Republic of China Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229 First Affiliated Hospital, Nanchang University, Jiangxi 330006, People's Republic of China.

Although ubiquitin receptor Rad23 has been implicated in bringing ubiquitylated p53 to the proteasome, how Rad23 recognizes p53 remains unclear. We demonstrate that XPC, a Rad23-binding protein, regulates p53 turnover. p53 protein in XPC-deficient cells remains ubiquitylated, but its association with the proteasome is drastically reduced, indicating that XPC regulates a postubiquitylation event. Furthermore, we found that XPC participates in the MDM2-mediated p53 degradation pathway via direct interaction with MDM2. XPC W690S pathogenic mutant is specifically defective for MDM2 binding and p53 degradation. p53 is known to become stabilized following UV irradiation but can be rendered unstable by XPC overexpression, underscoring a critical role of XPC in p53 regulation. Elucidation of the proteolytic role of XPC in cancer cells will help to unravel the detailed mechanisms underlying the coordination of DNA repair and proteolysis.

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016159 Tumor Suppressor Protein p53 Nuclear phosphoprotein encoded by the p53 gene (GENES, P53) whose normal function is to control CELL PROLIFERATION and APOPTOSIS. A mutant or absent p53 protein has been found in LEUKEMIA; OSTEOSARCOMA; LUNG CANCER; and COLORECTAL CANCER. p53 Tumor Suppressor Protein,Cellular Tumor Antigen p53,Oncoprotein p53,TP53 Protein,TRP53 Protein,p53 Antigen,pp53 Phosphoprotein,Phosphoprotein, pp53
D045643 DNA Repair Enzymes Enzymes that are involved in the reconstruction of a continuous two-stranded DNA molecule without mismatch from a molecule, which contained damaged regions. DNA Repair Enzyme,Enzyme, DNA Repair,Enzymes, DNA Repair,Repair Enzyme, DNA,Repair Enzymes, DNA
D046988 Proteasome Endopeptidase Complex A large multisubunit complex that plays an important role in the degradation of most of the cytosolic and nuclear proteins in eukaryotic cells. It contains a 700-kDa catalytic sub-complex and two 700-kDa regulatory sub-complexes. The complex digests ubiquitinated proteins and protein activated via ornithine decarboxylase antizyme. 20S Proteasome,Ingensin,Macropain,Macroxyproteinase,Multicatalytic Endopeptidase Complex,Multicatalytic Proteinase,Prosome,Proteasome,Complex, Multicatalytic Endopeptidase,Complex, Proteasome Endopeptidase,Endopeptidase Complex, Multicatalytic,Endopeptidase Complex, Proteasome,Proteasome, 20S,Proteinase, Multicatalytic
D051736 Proto-Oncogene Proteins c-mdm2 An E3 UBIQUITIN LIGASE that interacts with and inhibits TUMOR SUPPRESSOR PROTEIN P53. Its ability to ubiquitinate p53 is regulated by TUMOR SUPPRESSOR PROTEIN P14ARF. Mdm2 Protein,c-mdm2 Proto-Oncogene Protein,Double Minute 2 Protein,MDMX Protein,Mdm-2 Protein,Murine Double Minute 2 Protein,Mdm 2 Protein,Proto Oncogene Proteins c mdm2,Proto-Oncogene Protein, c-mdm2,c mdm2 Proto Oncogene Protein,c-mdm2, Proto-Oncogene Proteins
D059748 Proteolysis Cleavage of proteins into smaller peptides or amino acids either by PROTEASES or non-enzymatically (e.g., Hydrolysis). It does not include Protein Processing, Post-Translational. Protein Degradation,Protein Digestion,Degradation, Protein,Degradations, Protein,Digestion, Protein,Digestions, Protein,Protein Degradations,Protein Digestions,Proteolyses
D025801 Ubiquitin A highly conserved 76-amino acid peptide universally found in eukaryotic cells that functions as a marker for intracellular PROTEIN TRANSPORT and degradation. Ubiquitin becomes activated through a series of complicated steps and forms an isopeptide bond to lysine residues of specific proteins within the cell. These "ubiquitinated" proteins can be recognized and degraded by proteosomes or be transported to specific compartments within the cell. APF-1,ATP-Dependent Proteolysis Factor 1,HMG-20,High Mobility Protein 20,Ubiquitin, Human,ATP Dependent Proteolysis Factor 1,Human Ubiquitin

Related Publications

Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
March 2011, Nature medicine,
Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
November 2007, The Journal of biological chemistry,
Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
May 1997, Nature,
Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
March 2024, The Journal of biological chemistry,
Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
January 2008, Molecular cancer research : MCR,
Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
September 2002, Trends in biochemical sciences,
Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
October 1998, Molecular cell,
Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
January 2000, Gene,
Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
April 2019, Oncogene,
Jing Yan Krzeszinski, and Vitnary Choe, and Jia Shao, and Xin Bao, and Haili Cheng, and Shiwen Luo, and Keke Huo, and Hai Rao
December 2018, The Journal of pathology,
Copied contents to your clipboard!